Parminder Singh
Experienced in Transient Ischemic Attack (TIA)

Dr. Parminder Singh

Cardiology
Optum
Heart And Vascular Center Of Arizona
1331 N 7th St Ste 375, 
Phoenix, AZ 
On Staff At
Accepting New Patients
Offers Telehealth

Experienced in Transient Ischemic Attack (TIA)
Optum
Heart And Vascular Center Of Arizona
1331 N 7th St Ste 375, 
Phoenix, AZ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

To help people achieve health for life.

Dr. Singh is rated as an Experienced provider by MediFind in the treatment of Transient Ischemic Attack (TIA). His top areas of expertise are Arterial Embolism, Angina, Carotid Artery Disease, Transcatheter Aortic Valve Replacement (TAVR), and Aortic Valve Replacement.

His clinical research consists of co-authoring 59 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
Guru Nanak Dev University - India
Residency
Wayne State University School Of Medicine
Specialties
Cardiology
Licenses
Internal Medicine in AZ
Board Certifications
American Board Of Internal Medicine
Fellowships
University of Michigan Medical Center
Hospital Affiliations
Banner Estrella Medical Center
Banner Boswell Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Alignment Health Plan
  • MEDICARE MAPD
  • MEDICARE SNP
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
EmblemHealth
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE PART D
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medica
  • EPO
  • HMO
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MercyCare
  • EPO
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
UPMC
  • EPO
  • PPO
VibrantRx
  • MEDICARE PDP
  • OTHER MEDICARE
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Heart And Vascular Center Of Arizona
1331 N 7th St Ste 375, Phoenix, AZ 85006
Call: 602-307-0070
Other Locations
Cardiac Cath Lab Of Phoenix
1910 E Thomas Rd Ste 101, Phoenix, AZ 85016
Call: 480-470-0003

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


11 Clinical Trials

Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Other, Biological, Procedure
Study Drug: Pembrolizumab
Study Phase: Phase 3
A Pilot Study of Tazemetostat and Pembrolizumab (MK-3475) in Advanced Urothelial Carcinoma
A Pilot Study of Tazemetostat and Pembrolizumab (MK-3475) in Advanced Urothelial Carcinoma
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Procedure, Drug, Biological
Study Drugs: Pembrolizumab, Tazemetostat
Study Phase: Phase 1/Phase 2
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Phase III Randomized Trial of Concurrent Chemoradiotherapy With or Without Atezolizumab in Localized Muscle Invasive Bladder Cancer
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Other, Procedure, Drug, Radiation
Study Drugs: Atezolizumab, Cisplatin, Fluorouracil, Gemcitabine, Mitomycin C
Study Phase: Phase 3
A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients With Newly Diagnosed Metastatic Sensitive Prostate Cancer
A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients With Newly Diagnosed Metastatic Sensitive Prostate Cancer
Enrollment Status: Completed
Publish Date: December 31, 2025
Intervention Type: Drug
Study Drugs: TAK-700, Bicalutamide
Study Phase: Phase 3
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Phase II Trial of Atezolizumab in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Enrollment Status: Completed
Publish Date: May 22, 2025
Intervention Type: Drug
Study Drug: Atezolizumab
Study Phase: Phase 2
A Randomized Phase 2 Trial of Cisplatin/Gemcitabine With or Without M6620 (VX-970) in Metastatic Urothelial Carcinoma
A Randomized Phase 2 Trial of Cisplatin/Gemcitabine With or Without M6620 (VX-970) in Metastatic Urothelial Carcinoma
Enrollment Status: Completed
Publish Date: March 03, 2025
Intervention Type: Drug
Study Drugs: Berzosertib, Cisplatin, Gemcitabine Hydrochloride
Study Phase: Phase 2
Dose Escalation and Expansion Clinical Study to Evaluate the Safety and Efficacy of ELU001 in Subjects Who Have Advanced, Recurrent or Refractory FRα Overexpressing Tumors
Dose Escalation and Expansion Clinical Study to Evaluate the Safety and Efficacy of ELU001 in Subjects Who Have Advanced, Recurrent or Refractory FRα Overexpressing Tumors
Enrollment Status: Terminated
Publish Date: August 07, 2024
Intervention Type: Drug
Study Drug: ELU001
Study Phase: Phase 1/Phase 2
Phase 1 Study With Expansion Cohorts to Assess the Safety, Tolerability, and Activity of Oraxol (Paclitaxel + HM30181A) in Combination With Pembrolizumab in Subjects With Advanced Solid Malignancies
Phase 1 Study With Expansion Cohorts to Assess the Safety, Tolerability, and Activity of Oraxol (Paclitaxel + HM30181A) in Combination With Pembrolizumab in Subjects With Advanced Solid Malignancies
Enrollment Status: Terminated
Publish Date: May 19, 2023
Intervention Type: Drug, Biological
Study Phase: Phase 1
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for HER2 Negative Breast Cancer: The ABC Trial
Enrollment Status: Terminated
Publish Date: April 05, 2023
Intervention Type: Other, Drug
Study Drug: Aspirin
Study Phase: Phase 3
Phase II Study Evaluating Combination Chemotherapy + Radiotherapy (RT) With Avelumab in Muscle Invasive Bladder Cancer
Phase II Study Evaluating Combination Chemotherapy + Radiotherapy (RT) With Avelumab in Muscle Invasive Bladder Cancer
Enrollment Status: Completed
Publish Date: January 06, 2023
Intervention Type: Other, Radiation, Drug
Study Drugs: Avelumab, Cisplatin, 5-Fluorouracil, Mitomycin C
Study Phase: Phase 2
Proleukin Observational Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Proleukin Observational Registry to Evaluate the Treatment Patterns and Clinical Response in Malignancy
Enrollment Status: Completed
Publish Date: June 13, 2019
View 10 Less Clinical Trials

59 Total Publications

Circulating Tumor DNA in Urothelial Cancer: Practical Applications in Oncology Clinic.
Circulating Tumor DNA in Urothelial Cancer: Practical Applications in Oncology Clinic.
Journal: JCO oncology practice
Published: December 16, 2025
View All 59 Publications
Similar Doctors
Ashok Solsi
Advanced in Transient Ischemic Attack (TIA)
Dr. Ashok Solsi
Cardiology
Advanced in Transient Ischemic Attack (TIA)
Dr. Ashok Solsi
Cardiology

Premier Cardiovascular Center

77 S Dobson Rd, 
Chandler, AZ 
 (15.6 miles away)
480-814-0266
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dr. Solsi is the President and Founder of Premier Cardiovascular Center (PCC). The company was founded in December 2009 and began operating in January 2010. He has been practicing in the valley for past 19 years.Prior practice includes service at Arizona Heart Institute – East Valley in Mesa, Sacaton, Phoenix, Chandler and Casa Grande from 1997 to 2009 as an invasive cardiologist.Dr. Solsi is Board certified in Cardiovascular Medicine and Internal Medicine. He completed his Cardiology fellowship at Brooklyn Hospital Medical Center at New York University in New York (1997).He received his medical degree from Mysore Medical College in Mysore, India and he completed his internal medicine residency at Brooklyn Hospital Medical Center where he was chief resident during his final year.Dr. Solsi is Board certified and licensed in Nuclear Medicine and has certification to read CT Angiography.He is member and fellow of the American College of Cardiology and has published several articles on various cardiovascular topics. Currently he provides services at Chandler, Maricopa and Casa Grande.My goal is to provide the patient with excellent healthcare they need and deserve after explaining to them any issues pertaining to their cardiovascular care and treatment. I strive to make sure patients understand their heart realted issues and provide education for them to improve their health. As the CEO and founder of the organization, it is our mission that all our employees and providers follow the same goals and philosophy for all our patients. Dr. Solsi is rated as a Distinguished provider by MediFind in the treatment of Transient Ischemic Attack (TIA). His top areas of expertise are Coronary Heart Disease, Atherosclerosis, Angina, and Glucocorticoid-Remediable Aldosteronism.

Alan Grossman
Advanced in Transient Ischemic Attack (TIA)
Dr. Alan Grossman
Cardiology
Advanced in Transient Ischemic Attack (TIA)
Dr. Alan Grossman
Cardiology

Cardiovascular Associates Of Mesa

6309 E Baywood Ave Ste 101, 
Mesa, AZ 
 (20.6 miles away)
480-641-5400
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Alan Grossman is a Cardiologist in Mesa, Arizona. Dr. Grossman is rated as a Distinguished provider by MediFind in the treatment of Transient Ischemic Attack (TIA). His top areas of expertise are Cardiomyopathy, Adenosine Deaminase 2 Deficiency, Arterial Embolism, and Angina. Dr. Grossman is currently accepting new patients.

Alphonse Ambrosia
Advanced in Transient Ischemic Attack (TIA)
Dr. Alphonse Ambrosia
Cardiology
Advanced in Transient Ischemic Attack (TIA)
Dr. Alphonse Ambrosia
Cardiology

Cardiovascular Associates Of Mesa

6309 E Baywood Ave Ste 101, 
Mesa, AZ 
 (20.6 miles away)
480-641-5400
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Dr. Alphonse Ambrosia is a board-certified interventional cardiologist with expertise in coronary artery disease, heart failure, hypertensive heart disease, stroke and carotid artery disease, coronary angiography and angioplasty, carotid angioplasty and stenting, renal artery angioplasty and stenting, TEE, PFO closure, TAVI procedure, and Watchman procedure. Dr. Ambrosia earned his medical degree from the College of Osteopathic Medicine of the Pacific. He completed his internship at Mesa General Hospital and his residency and post-doctoral fellowship at Good Samaritan Regional Medical Center (Phoenix, AZ). Dr. Ambrosia was awarded the AOMA Humanitarian Award in 2018, along with Top Doctor Recognitions in 2012 and 2014.My desire, as a physician with CVAM Cardiology, is that we will provide you with the best cardiac care possible.  We will deliver the most advanced coronary and cardiac interventional techniques and technology in both the hospital and office.  We will provide this in a relaxed setting that will allow you to have all your concerns addressed. Dr. Ambrosia is rated as a Distinguished provider by MediFind in the treatment of Transient Ischemic Attack (TIA). His top areas of expertise are Heart Failure with Preserved Ejection Fraction (HFpEF), Heart Failure, Pulmonary Edema, Pacemaker Implantation, and Aortic Valve Replacement.

VIEW MORE TRANSIENT ISCHEMIC ATTACK (TIA) DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Singh's expertise for a condition
ConditionClose
      • Advanced
      • Adenosine Deaminase 2 Deficiency
        Dr. Singh is
        Advanced
        . Learn about Adenosine Deaminase 2 Deficiency.
        See more Adenosine Deaminase 2 Deficiency experts
      • Angina
        Dr. Singh is
        Advanced
        . Learn about Angina.
        See more Angina experts
      • Apoplexy
        Dr. Singh is
        Advanced
        . Learn about Apoplexy.
        See more Apoplexy experts
      • Arterial Embolism
        Dr. Singh is
        Advanced
        . Learn about Arterial Embolism.
        See more Arterial Embolism experts
      • Atherosclerosis
        Dr. Singh is
        Advanced
        . Learn about Atherosclerosis.
        See more Atherosclerosis experts
      • Atrial Fibrillation
        Dr. Singh is
        Advanced
        . Learn about Atrial Fibrillation.
        See more Atrial Fibrillation experts
      View All 23 Advanced Conditions
      • Experienced
      • Acute Coronary Syndrome
        Dr. Singh is
        Experienced
        . Learn about Acute Coronary Syndrome.
        See more Acute Coronary Syndrome experts
      • Aortic Regurgitation
        Dr. Singh is
        Experienced
        . Learn about Aortic Regurgitation.
        See more Aortic Regurgitation experts
      • Aortic Valve Replacement
        Dr. Singh is
        Experienced
        . Learn about Aortic Valve Replacement.
        See more Aortic Valve Replacement experts
      • Aortic Valve Stenosis
        Dr. Singh is
        Experienced
        . Learn about Aortic Valve Stenosis.
        See more Aortic Valve Stenosis experts
      • Arrhythmias
        Dr. Singh is
        Experienced
        . Learn about Arrhythmias.
        See more Arrhythmias experts
      • Arrhythmogenic Right Ventricular Cardiomyopathy
        Dr. Singh is
        Experienced
        . Learn about Arrhythmogenic Right Ventricular Cardiomyopathy.
        See more Arrhythmogenic Right Ventricular Cardiomyopathy experts
      View All 62 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile
      For Patients
      • Our Story
      • How MediFind Works
      • Conditions A-Z
      • Doctor Directory
      • Symptoms Directory
      • Procedures Directory
      • Treatment Directory
      • Drug Directory
      • Infusion Center Finder
      • FAQ
      • Contact Us
      For Providers and Practices
      • Claim Your Profile
      • Newsroom
      Business Solutions
      • Provider
      • Network Solutions
      Additional Resources
      • Consumer Health Data Privacy Policy
      • Privacy Policy
      • Terms of Use
      • Advertising Policy
      • Content Policy
      Subscribe to our newsletter

      Sign up to stay informed about MediFind and get wellness sent your way.

      Close

        By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

        Bullet PinMediFind
        Follow us on
        This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
        © 2026 All Rights Reserved

        Request an Appointment

        If you are experiencing a medical emergency, call 9-1-1.

        Once you submit your request, MediFind will reach out to the provider’s office to help schedule your appointment. Note that this is not a confirmed booking. You’ll receive a status update via email within 1–2 business days.

        Patient Details

        This information is for the patient who will be seen at the appointment.

            Close

            Returning patient? Use your address on file with the provider.

            Insurance Details

            Please provide information of the primary insurance holder as the practice may require this information to schedule.

            Insurance Provider *
            Insurance ProviderClose

            Appointments Details

            Let’s get more information about your appointment.

                    0 / 1000
                    By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.